You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: December 5, 2023

Details for Patent: 8,486,973

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,486,973 protect, and when does it expire?

Patent 8,486,973 protects SUBSYS and is included in one NDA.

This patent has nine patent family members in nine countries.

Summary for Patent: 8,486,973

Title:	Sublingual fentanyl spray
Abstract:	The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s):	Kottayil; S. George (Phoenix, AZ), Goskonda; Venkat R. (Gurnee, IL), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Des Plaines, IL), Parikh; Neha (Chicago, IL)
Assignee:	Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:	12/221,333
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,486,973
Patent Claim Types: see list of patent claims	Use; Formulation; Composition; Delivery; Device;

Drugs Protected by US Patent 8,486,973

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-001	Jan 4, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF PAIN	⤷ Try a Trial
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-002	Jan 4, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF PAIN	⤷ Try a Trial
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-003	Jan 4, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF PAIN	⤷ Try a Trial
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-004	Jan 4, 2012		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				TREATMENT OF PAIN	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,486,973

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008282743	⤷ Try a Trial
Canada	2698749	⤷ Try a Trial
Denmark	2180844	⤷ Try a Trial
European Patent Office	2180844	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey

AstraZeneca

Dow

Boehringer Ingelheim

Express Scripts

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.